Sponsored by
OWT
3 months ago
Get an EXTRA 20% OFF your hosting plan!
Hostinger's got a HOT deal! Get an EXTRA 20% OFF your hosting! Don't miss out!
Macrolide Antibiotics Market In-Depth Expert Analysis including Trends, Share, Size and Forecast 2024 - 2031
Global Macrolide Antibiotics Market, By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories) – Industry Trends and Forecast to 2029
Global Macrolide Antibiotics Market Analysis and Size
Macrolide antibiotics are known to possess immunomodulatory and anti-inflammatory effects that are utilized for certain health conditions. The rise in the prevalence for infectious diseases is escalating the growth of macrolide antibiotics market.
Global Macrolide Antibiotics Market was valued at USD 55,287.85 million in 2021 and is expected to reach USD 146,979.68 million by 2029, registering a CAGR of 13.00% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample PDF of report - https://www.databridgemark...
Global Macrolide Antibiotics Market Definition
Macrolides refer to a class of antibiotics that are derived from Saccharopolyspora erythraea, and inhibit protein synthesis in bacteria by binding to the 50S ribosomal element. These antibiotics are effective against gram positive bacteria and intracellular pathogens, such as Chlamydia and Mycoplasma and Legionella.
Report Metric
Details
Forecast Period
2022 to 2029
Base Year
2021
Historic Years
2020 (Customizable to 2019 - 2014)
Quantitative Units
Revenue in USD Million, Volumes in Units, Pricing in USD
Segments Covered
Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories)
Countries Covered
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest
Global Macrolide Antibiotics Market, By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories) – Industry Trends and Forecast to 2029
Global Macrolide Antibiotics Market Analysis and Size
Macrolide antibiotics are known to possess immunomodulatory and anti-inflammatory effects that are utilized for certain health conditions. The rise in the prevalence for infectious diseases is escalating the growth of macrolide antibiotics market.
Global Macrolide Antibiotics Market was valued at USD 55,287.85 million in 2021 and is expected to reach USD 146,979.68 million by 2029, registering a CAGR of 13.00% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get a Sample PDF of report - https://www.databridgemark...
Global Macrolide Antibiotics Market Definition
Macrolides refer to a class of antibiotics that are derived from Saccharopolyspora erythraea, and inhibit protein synthesis in bacteria by binding to the 50S ribosomal element. These antibiotics are effective against gram positive bacteria and intracellular pathogens, such as Chlamydia and Mycoplasma and Legionella.
Report Metric
Details
Forecast Period
2022 to 2029
Base Year
2021
Historic Years
2020 (Customizable to 2019 - 2014)
Quantitative Units
Revenue in USD Million, Volumes in Units, Pricing in USD
Segments Covered
Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin), Route of Administration (Oral and Parenteral), Infection (Mycoplasma pneumoniae, Legionella sp., Bordetella pertussis, Symptomatic Cat-Scratch Disease, Bacillary angiomatosis, Peliosishepatis, Cerebral Toxoplasmosis and Uncomplicated Skin Infections), End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre and Research Laboratories)
Countries Covered
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest
06:02 PM - Jun 10, 2024 (UTC)
The Revolutionary Blood Cell Analysis Technology: How Erythromycin is Transforming Medical Diagnostics
Erythrom represents a groundbreaking advancement in hematological analysis, combining artificial intelligence with sophisticated microscopy to revolutionize how medical professionals examine and analyze blood cells. This innovative technology platform has emerged as a game-changer in diagnostic medicine, offering unprecedented accuracy and efficiency in blood cell analysis while significantly reducing the time and resources required for traditional manual methods.
Erythromycin - https://prateikcmi.hashnod...
#Erythrom #Erythromycin #ModernMedicine #RedBloodCellTherapy
#PharmaceuticalInnovation #CoherentMarketInsights
Erythrom represents a groundbreaking advancement in hematological analysis, combining artificial intelligence with sophisticated microscopy to revolutionize how medical professionals examine and analyze blood cells. This innovative technology platform has emerged as a game-changer in diagnostic medicine, offering unprecedented accuracy and efficiency in blood cell analysis while significantly reducing the time and resources required for traditional manual methods.
Erythromycin - https://prateikcmi.hashnod...
#Erythrom #Erythromycin #ModernMedicine #RedBloodCellTherapy
#PharmaceuticalInnovation #CoherentMarketInsights
06:06 AM - Apr 11, 2025 (UTC)
Erythromycin: A Widely Used Macrolide Antibiotic
History of Erythromycin
Erythromycin was first isolated from cultures of the actinobacterium Saccharopolyspora erythraea (formerly Streptomyces erythreus) in 1952 by a Greek-American microbiologist named Abelardo A. Broth. Initial work by Brock led to the discovery that the active substance he had isolated had antibacterial properties. Further research and development resulted in the introduction of erythromycin as a clinically useful antibiotic in the 1950s. It was one of the first commercially produced semi-synthetic antibiotics.
Erythromycin - https://www.coherentmarket...
History of Erythromycin
Erythromycin was first isolated from cultures of the actinobacterium Saccharopolyspora erythraea (formerly Streptomyces erythreus) in 1952 by a Greek-American microbiologist named Abelardo A. Broth. Initial work by Brock led to the discovery that the active substance he had isolated had antibacterial properties. Further research and development resulted in the introduction of erythromycin as a clinically useful antibiotic in the 1950s. It was one of the first commercially produced semi-synthetic antibiotics.
Erythromycin - https://www.coherentmarket...
Erythromycin Market - Share, Size and Industry Analysis
Erythromycin Market is segmented By Formulation (Gel, Tablet, Topical Solution, Ointment, and Others) and Disease Indication (Respiratory Tract Infections, Eye Infections, Ear Infections)
https://www.coherentmarketinsights.com/market-insight/erythromycin-market-1780
12:54 PM - Jan 16, 2025 (UTC)
